Latest news

The Most Powerful Oncology Tool This Week Was a Check-In
New PRO-TECT findings show weekly electronic symptom monitoring improved symptom control and physical function during advanced cancer treatment, with especially strong benefits for underserved groups. The technology is simple. The equity lesson is not.

Infant Formula Botulism Turns Food Safety Into a Baby-Safety Emergency

Personalised cardiology cannot succeed if women’s hearts still follow men’s pathways

AstraZeneca’s Baxfendy opens a new front in uncontrolled hypertension, but monitoring will decide who benefits

Cancer Is Chaos. Patients Should Not Have to Become Their Own Operating System

India’s emergency price-cap rise for cisplatin and carboplatin exposes a blunt oncology truth

Huntington’s Gene Therapy Moves Back Toward the FDA Door

G7 Cancer Call and WHA Precision Medicine Resolution: A Moment to Turn Ambition Into Delivery

Alzheimer’s Research Moves Beyond Amyloid

Ebola in Congo’s Camps Shows the Human Cost of Lost Trust
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
